Meng Wang, Satoshi Fukushima, Yi-Shuan Sheen, Egle Ramelyte, Noel Cruz-Pacheco, Chenxu Shi, Shanshan Liu, Ishani Banik, Jamie D. Aquino, Martin Sangueza Acosta, Mitchell Levesque, Reinhard Dummer, Jau-Yu Liau, Chia-Yu Chu, A. Hunter Shain, Iwei Yeh, and Boris C. Bastian
Abstract Acral melanoma is an aggressive type of melanoma with unknown origins. It is the most common type of melanoma in individuals with dark skin and is notoriously challenging to treat. We examine exome sequencing data of 139 tissue samples, spanning different progression stages, from 37 patients. We find that 78.4% of the melanomas display clustered copy number transitions with focal amplifications, recurring predominantly on chromosomes 5, 11, 12, and 22. These complex genomic aberrations are typically shared across all progression stages of individual patients. TERT activating alterations also arise early, whereas MAP-kinase pathway mutations appear later, an inverted order compared to the canonical evolution. The punctuated formation of complex aberrations and early TERT activation suggest a unique mutational mechanism that initiates acral melanoma. The marked intratumoral heterogeneity, especially concerning MAP-kinase pathway mutations, may partly explain the limited success of therapies for this melanoma subtype.